Is Testosterone a Protein or a Steroid Hormone?

Testosterone is a steroid hormone, not a protein. The two belong to fundamentally different chemical categories: proteins are long chains of amino acids, while steroid hormones are small, fat-soluble molecules built from cholesterol. That cholesterol backbone is precisely what gives testosterone its ability to slip through cell membranes and directly influence gene activity, something a protein hormone like insulin cannot do on its own. The confusion between the two is understandable, though, because testosterone spends most of its time in the bloodstream attached to proteins, and its effects inside cells depend on a protein receptor.

What Makes Testosterone a Steroid

Steroids share a characteristic four-ring carbon structure derived from cholesterol. Testosterone fits neatly into this family alongside cortisol, estradiol, and aldosterone. All of these molecules are fat-soluble, meaning they dissolve readily in lipids rather than water. That property shapes almost everything about how testosterone behaves in the body, from how it is made, to how it travels through the bloodstream, to how it enters a target cell.

Steroid hormones like testosterone are synthesized from cholesterol in specialized glandular cells found in the testes, ovaries, and adrenal glands, then released into the circulation as needed.¹ Because they are lipophilic (fat-loving), they can pass directly through cell membranes without needing a special channel or docking protein on the cell surface. Protein hormones, by contrast, are water-soluble and too large to cross the fatty membrane. They have to bind to receptors on the outside of the cell and trigger a relay of signals inward. This is the core structural difference, and it dictates completely different mechanisms of action.

Why Testosterone Is Often Confused With Proteins

One reason the question keeps coming up is that testosterone, despite being fat-soluble, spends most of its time in the blood bound to proteins. Blood is water-based, so a fat-soluble molecule on its own would have trouble staying dissolved. To get around this, testosterone hitches a ride on carrier proteins. The main ones are sex hormone-binding globulin (SHBG), which holds testosterone tightly, and serum albumin, the most abundant protein in blood plasma, which binds it more loosely.² A small residual fraction also binds to other plasma proteins.³

Only a tiny percentage of testosterone circulates “free,” unbound to any protein. That free fraction is what crosses into tissues most readily. But the protein-bound testosterone is not inactive luggage; it serves as a circulating reservoir. The binding proteins influence how quickly testosterone is delivered to various tissues. SHBG, for instance, slows the rate at which testosterone crosses from blood into the brain, delaying its appearance in cerebrospinal fluid under non-equilibrium conditions.⁴ So the carrier proteins are not just passive taxis. They regulate the pace and pattern of testosterone delivery throughout the body.

The takeaway: testosterone needs proteins to travel, but it is not itself a protein. A useful analogy is that a passenger is not a bus simply because they ride one.

How Testosterone Works Once It Reaches a Cell

When free testosterone arrives at a target cell, its fat-soluble nature lets it pass right through the outer membrane. Inside, it binds to the androgen receptor, a protein that sits in the cytoplasm waiting for a hormone to arrive. The androgen receptor belongs to the nuclear receptor family, a group of proteins that act as ligand-dependent transcription factors. In plain terms, once testosterone locks in, the receptor changes shape, travels into the nucleus, and binds to specific stretches of DNA to switch genes on or off.⁵

The androgen receptor’s hormone-binding region sits at its tail end, spanning roughly 250 amino acid residues. Without testosterone or another androgen attached, this region actually inhibits the receptor’s activity, keeping it quiet. When the hormone binds, that inhibition lifts, and the receptor moves into the nucleus and activates gene transcription.⁶ This genomic pathway, where hormone binds receptor which then changes gene expression, is the classic route for steroid hormone action, and it is fundamentally different from how a protein hormone like growth hormone works through cell-surface receptors and signaling cascades.

Rapid Actions That Skip the Genome

The genomic pathway takes time, typically hours, because genes need to be transcribed and proteins need to be built. But researchers noticed decades ago that some of testosterone’s effects happen far too quickly to be explained by gene activation. Certain cellular responses begin within seconds to minutes and persist even when the machinery for transcription is chemically blocked.⁷

These rapid, non-genomic actions originate at or near the cell membrane. In skeletal muscle cells, for instance, androgens can trigger a quick burst of calcium release from internal stores and activate signaling cascades that boost force production almost immediately.⁸ Within five minutes of testosterone treatment, researchers have measured the rapid phosphorylation of multiple signaling molecules involved in cell growth and survival pathways.⁹

This dual-mode operation is one of the more interesting aspects of steroid hormones in general. Testosterone does not simply enter a cell and flip genetic switches. It also sets off fast signaling events that look more like the pathways protein hormones use, blurring what once seemed like a clean dividing line between the two hormone classes. The distinction still holds at the chemical level, but functionally, the categories overlap more than textbooks used to suggest.

From Cholesterol to Testosterone

Testosterone production in males happens primarily in the Leydig cells of the testes, under direction from luteinizing hormone (LH) released by the pituitary gland.¹⁰ The raw material is cholesterol, which is shuttled into the mitochondria of Leydig cells by a transport protein called StAR. From there, a series of enzymatic steps progressively reshape the cholesterol molecule. Cholesterol is first cleaved into pregnenolone, which is then converted through intermediates like progesterone and androstenedione until the final product, testosterone, emerges.¹¹

At least four major enzymes are involved in this chain, each modifying a different part of the steroid skeleton.¹² The entire process is sometimes called steroidogenesis, and it happens not just in the testes but also on a smaller scale in the adrenal glands and ovaries.¹³ Women produce testosterone too, just in much smaller amounts, and it plays roles in libido, bone density, and muscle maintenance for all sexes.

Understanding this pathway matters for a practical reason: anything that disrupts cholesterol availability or any of those enzymes can reduce testosterone production. Certain drugs, diseases of the adrenal glands, and even environmental chemicals known as endocrine disruptors can interfere with the synthesis or action of sex hormones.¹⁴

Testosterone Does Not Always Stay as Testosterone

Once testosterone enters the bloodstream, it does not necessarily remain in its original form. In many target tissues, enzymes convert it into other active hormones. The enzyme 5-alpha reductase transforms testosterone into dihydrotestosterone (DHT), a more potent androgen that drives hair follicle behavior, prostate growth, and certain aspects of male sexual development. Another enzyme, aromatase, converts testosterone into estradiol, an estrogen. Many of testosterone’s downstream effects, from bone density maintenance to changes in body composition, are actually mediated through these two metabolites.¹⁵

The conversions follow dose-dependent, saturable kinetics, meaning the enzymes work harder as testosterone levels rise but eventually reach a ceiling.¹⁶ This is why very high supraphysiological doses of testosterone, like those used in illicit doping, can paradoxically produce estrogenic side effects such as breast tissue growth. The aromatase enzyme converts the excess testosterone into estradiol faster than the body can clear it.

DHT, for its part, binds the androgen receptor with roughly twice the affinity of testosterone itself, which helps explain why DHT-sensitive tissues like the prostate and scalp hair follicles are so responsive even to small amounts.¹⁷ Drugs that block 5-alpha reductase (like finasteride) reduce DHT production and are used to treat both enlarged prostates and pattern hair loss, precisely because they cut off testosterone’s conversion into this stronger derivative.

The Feedback Loop That Keeps Levels in Check

Testosterone production is governed by a feedback circuit called the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases a signaling hormone (GnRH) that tells the pituitary gland to secrete LH and FSH, which in turn stimulate the testes to produce testosterone. When testosterone levels rise high enough, the signal feeds back to the hypothalamus and dials down GnRH release, which in turn reduces LH secretion, which slows testosterone production. This keeps blood levels within a homeostatic range.

Interestingly, GnRH-producing neurons do not themselves carry androgen receptors. Instead, testosterone acts on a separate population of neurons in the hypothalamus that express a peptide called kisspeptin. These kisspeptin neurons are the ones that regulate GnRH pulsatility, so testosterone’s negative feedback is indirect.¹⁸ This detail matters clinically because people who take exogenous testosterone (for hormone therapy or performance enhancement) effectively shut down their own HPG axis. The brain senses elevated testosterone, suppresses LH, and the testes receive no signal to produce testosterone or maintain sperm production. That is why testosterone therapy can impair fertility and why testicular atrophy is a common side effect of anabolic steroid misuse.

How Testosterone Builds Muscle

One of the most well-known effects of testosterone is its role in promoting muscle growth, which is why it is classified as an anabolic-androgenic steroid. The anabolic part refers to tissue building; the androgenic part refers to the development of male sexual characteristics. In muscle tissue, testosterone stimulates protein synthesis directly. Research has shown an average increase of about 27% in muscle protein synthesis with testosterone administration, without a corresponding rise in whole-body protein breakdown.¹⁹

Beyond simply ramping up protein production within existing muscle fibers, testosterone also activates satellite cells, the dormant repair and growth cells that sit on the surface of muscle fibers. When a muscle fiber grows large enough that its existing nuclei can no longer sustain further protein synthesis, these satellite cells fuse with the fiber and donate new nuclei, allowing the fiber to keep growing.²⁰ This two-pronged mechanism, boosting protein synthesis and recruiting new cellular nuclei, is why testosterone has such a pronounced effect on muscle mass compared to other interventions.

Why Pharmaceutical Testosterone Is Modified

If testosterone is already a natural molecule, why can’t it simply be injected as-is for hormone replacement? It can be, but unmodified testosterone has a very short half-life. When injected directly into the bloodstream, it disappears from circulation within about ten minutes. To make it practical for therapy, pharmaceutical chemists attach an ester group to the molecule at its 17-beta carbon position. This makes testosterone more soluble in oil, allowing it to be injected intramuscularly and released slowly from the injection site over days or weeks.²¹

Different ester attachments produce different release profiles. Testosterone enanthate, one of the most commonly prescribed forms, creates a spike-and-trough pattern with injections every one to two weeks. Testosterone undecanoate, a longer-chain ester, provides more stable levels over a longer interval.²² Other delivery methods, including transdermal gels, patches, and subcutaneous pellets, aim to mimic the body’s natural daily rhythm of testosterone secretion more closely. Once any of these formulations release testosterone into the body, the ester is cleaved off and the molecule that acts on tissues is the same natural steroid.

Selective Androgen Receptor Modulators

Because testosterone affects nearly every tissue that carries an androgen receptor, it is a blunt instrument in some therapeutic contexts. A person being treated for muscle wasting from chronic illness, for example, might benefit from testosterone’s anabolic effects on muscle and bone but not from its stimulatory effects on the prostate. This limitation spurred the development of selective androgen receptor modulators, or SARMs, which aim to activate the androgen receptor preferentially in muscle and bone while minimizing activity in reproductive tissues.²³

Nonsteroidal SARMs represent a newer class that does not share the four-ring steroid backbone of testosterone. Because of their different chemical structure, they are not converted by aromatase into estrogens or by 5-alpha reductase into DHT, which eliminates some of the side effects associated with testosterone therapy.²⁴ Most nonsteroidal SARMs remain in clinical development or are available only as research chemicals, and none have received broad regulatory approval for general use. They are worth knowing about, though, because they illustrate how tightly the steroid structure of testosterone is linked to its broad tissue effects, and why changing that structure changes the entire biological profile.

Testosterone in the Wider Animal Kingdom

Testosterone is not a uniquely human molecule. It appears across vertebrates, from fish to birds to mammals, playing roles in aggression, mating behavior, territorial defense, and physical development. Evolutionary analyses suggest that the androgen receptor, the protein that responds to testosterone, appeared relatively late in vertebrate evolution, after the divergence of jawless fish. An ancestor of the estrogen receptor came first, and the androgen receptor arose through gene duplication events in jawed vertebrates.²⁵ The steroidogenic enzymes needed to produce testosterone co-evolved alongside these receptors at key transitions in vertebrate history.²⁶

One of the more striking demonstrations of testosterone’s power across species is its role in sex determination. In several groups of vertebrates, administering sex steroids to embryos can completely override genetic sex. Androgens can induce female-to-male sex reversal, and estrogens can do the reverse.²⁷ In reptiles with temperature-dependent sex determination, such as snapping turtles, injecting estradiol into eggs incubated at male-producing temperatures causes all embryos to develop as females. Testosterone propionate also feminized a substantial fraction of embryos in the same experiments, likely because the turtles’ own aromatase enzyme converted the testosterone into estradiol.²⁸ This finding reinforces a recurring theme: testosterone is not always the end of the line. Its metabolites, especially estradiol, are frequently the molecules that carry out the final biological effect, even when testosterone gets the credit.